Aviva’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Buy
21,567
+3,876
+22% +$85.7K ﹤0.01% 762
2026
Q1
$412K Buy
17,691
+7,443
+73% +$232K ﹤0.01% 781
2025
Q4
$454K Buy
10,248
+3,431
+50% +$193K ﹤0.01% 826
2025
Q3
$499K Sell
6,817
-1,793
-21% -$117K ﹤0.01% 748
2025
Q2
$528K Sell
8,610
-672
-7% -$37.5K ﹤0.01% 701
2025
Q1
$539K Sell
9,282
-2,227
-19% -$141K ﹤0.01% 785
2024
Q4
$614K Sell
11,509
-5,348
-32% -$262K ﹤0.01% 682
2024
Q3
$734K Sell
16,857
-5,361
-24% -$179K ﹤0.01% 648
2024
Q2
$621K Sell
22,218
-714
-3% -$18.8K ﹤0.01% 742
2024
Q1
$617K Sell
22,932
-1,440
-6% -$41K ﹤0.01% 835
2023
Q4
$683K Buy
+24,372
New +$576K ﹤0.01% 747

Other funds holding DOCS

Aviva's DOCS Position: Q2 2026 in Review

Aviva increased its Doximity (DOCS) stake by 22% in Q2 2026, buying an estimated $85.7K and bringing the position to 21,567 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Aviva first reported a position in DOCS in Q4 2023 and has held it in 11 quarters since. The position peaked at $734K in Q3 2024. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Aviva held 21,567 shares of Doximity worth $447K as of Q2 2026.
  • Aviva bought 3,876 Doximity shares in Q2 2026, an estimated $85.7K.
  • Doximity made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #762 holding.
  • Aviva first reported a position in Doximity in Q4 2023 and has held it in 11 quarters since.
  • Aviva's Doximity position peaked at $734K in Q3 2024.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.